BioCardia (NASDAQ: BCDA) CEO adds 1,700 shares in May open‑market buys
BioCardia, Inc. (NASDAQ: BCDA) President and CEO Peter Altman recently purchased 1,700 shares of the company's common stock through open-market transactions. These purchases, totaling $1,570, involved 200 shares bought at $0.95 and 1,500 shares at $0.92, increasing his direct holdings to 293,266 shares. The transactions, detailed in a Form 4 SEC filing, reflect insider confidence in the biotechnology company.
APR 30·Stock Titan▲
BioCardia (NASDAQ: BCDA) CEO adds 5,000 shares at $1.11
BioCardia, Inc.'s President and CEO, Peter Altman, purchased 5,000 shares of the company's Common Stock at $1.11 per share on April 29, 2026. This open-market transaction increased his direct holdings to 280,766 shares. The filing indicates a net buying activity, signaling confidence from the insider.
APR 29·Investing.com▲
BioCardia CEO Peter Altman buys $5,550 in common stock
BioCardia Inc. CEO Peter Altman purchased 5,000 shares of common stock for $5,550 on April 29, 2026, increasing his direct ownership to 280,766 shares. This transaction follows a significant decline in the stock's value, which is currently near its 52-week low. The company recently reported Q4 2025 financial results and is advancing its CardiAMP therapy with positive regulatory feedback in both the U.S. and Japan.
